ResearcherUniversity of Chieti-PescaraNo recent work listed
Verena Damiani
Matched on ORCID iD 0000-0003-2833-841X; OpenAlex author ID A5055679361. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2018: 1 paper · 2019: 3 papers · 2020: none · 2021: none · 2022: 1 paper
Papers 5
- Proteomics Approach Highlights Early Changes in Human Fibroblasts-Pancreatic Ductal Adenocarcinoma Cells Crosstalk. Co-author DOI 10.3390/cells11071160↗
- Development of an anti-BAG3 humanized antibody for treatment of pancreatic cancer. Co-author DOI 10.1002/1878-0261.12492↗
- ABCC3 is a novel target for the treatment of pancreatic cancer. Co-author DOI 10.1016/j.jbior.2019.04.004↗
- Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer. Co-author DOI 10.1186/s13046-019-1308-7↗
- Combined effect of anti-BAG3 and anti-PD-1 treatment on macrophage infiltrate, CD8+ T cell number and tumour growth in pancreatic cancer. Co-author DOI 10.1136/gutjnl-2017-314225↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Vincenzo De Laurenzi · 5 shared papers, 2018–2022 · strength 0.45
- Paper Proteomics Approach Highlights Early Changes in Human Fibroblasts-Pancreatic Ductal Adenocarcinoma Cells Crosstalk. DOI 10.3390/cells11071160↗
- Paper ABCC3 is a novel target for the treatment of pancreatic cancer. DOI 10.1016/j.jbior.2019.04.004↗
- Paper Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer. DOI 10.1186/s13046-019-1308-7↗
- Maria Caterina Turco · 3 shared papers, 2018–2022 · strength 0.29
- Paper Proteomics Approach Highlights Early Changes in Human Fibroblasts-Pancreatic Ductal Adenocarcinoma Cells Crosstalk. DOI 10.3390/cells11071160↗
- Paper Development of an anti-BAG3 humanized antibody for treatment of pancreatic cancer. DOI 10.1002/1878-0261.12492↗
- Paper Combined effect of anti-BAG3 and anti-PD-1 treatment on macrophage infiltrate, CD8+ T cell number and tumour growth in … DOI 10.1136/gutjnl-2017-314225↗
- Alice Domenichini · 2 shared papers, 2019 · strength 0.17
- Aleksandra Adamska · 2 shared papers, 2019 · strength 0.17
- Marco Falasca · 2 shared papers, 2019 · strength 0.17
- Alessandra Rosati · 2 shared papers, 2018–2019 · strength 0.14
- Vittoria Iorio · 2 shared papers, 2018–2019 · strength 0.14
- Anna Maria Basile · 2 shared papers, 2018–2019 · strength 0.14
- Margot De Marco · 2 shared papers, 2018–2019 · strength 0.14
- Liberato Marzullo · 2 shared papers, 2018–2019 · strength 0.14
- Riccardo Ferro · 1 shared paper, 2019 · strength 0.09
- Yulia Y. Maxuitenko · 1 shared paper, 2019 · strength 0.08
- Adam B. Keeton · 1 shared paper, 2019 · strength 0.08
- Pierluigi Di Sebastiano · 1 shared paper, 2019 · strength 0.08
- Gary Anthony Piazza · 1 shared paper, 2019 · strength 0.08
- Claudio Arra · 1 shared paper, 2019 · strength 0.08
- Maria Carmela Pascale · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.